Related Experiment Video
Updated: Jul 13, 2026

An Atmospheric Pressure Plasma Setup to Investigate the Reactive Species Formation
Published on: November 3, 2016
Viral inactivation of murine coronavirus via multiple gas plasma-derived reactive species
Sander Bekeschus1, Meike Heuser2, Lea Miebach2
1ZIK Plasmatis, Leibniz Institute for Plasma Science and Technology (INP), Leibniz Health Research Alliance, 17489, Greifswald, Germany; Department of Dermatology and Venerology, Rostock University Medical Center, 18057, Rostock, Germany.
Abstract:
The recent pandemic has highlighted the urgent need to elucidate the pathophysiological mechanisms underlying viral effects in humans and is driving the search for innovative antiviral therapies. Several studies have investigated the ability of gas plasma, a partially ionized gas that simultaneously generates several reactive species, to be a new antiviral tool. However, several aspects of the mechanisms of antiviral action of gas plasma remained elusive. In this study, we, for the first time, used a gas plasma device approved for medical purposes and routinely applied in the clinics, especially for wound healing, to test its antiviral activity against a murine corona-virus in vitro (MHV-GFP), a research model analogous to human coronaviruses such as SARS-CoV-2. For this, we established a novel high-content imaging assay that gave quantitative and kinetic information about infection and reduced viral activity in murine fibroblasts (17Cl-1) host cells. Gas plasma treatment delayed viral infectivity and reduced overall infection and toxicity in 17Cl1 cells. Various antioxidants at different concentrations were screened to identify ROS relevant to antiviral effects. Catalase provided no virus protection, and DMSO, mannitol, histidine, Trolox, and ascorbic acid only modestly reduced gas plasma virucidal efficacy. By contrast, glutathione, tyrosine, and cysteine showed profound but not complete protection of MHV from gas plasma-derived reactive species, suggesting pivotal roles of superoxide radicals and peroxynitrite gas in plasma-driven viral inactivation. At extended gas plasma exposure times, fewer intact MHV RNA were detected, indicative of reactive species-driven RNA modifications or degradation as an additional mechanism of action. Virus particle size changes measured by electron microscopy were moderate. Collectively, we identified the potent antiviral activity of a clinically approved argon plasma jet along with potential mechanisms of action.
Insights
This study shows that a clinically approved argon gas plasma jet effectively inactivates murine coronavirus (MHV-GFP) in vitro. Key reactive species like superoxide radicals and peroxynitrite are identified as crucial for this potent antiviral effect.
Area of Science:
- Biophysics
- Infectious Diseases
- Biotechnology
Background:
- The COVID-19 pandemic underscores the need for novel antiviral therapies.
- Gas plasma is being explored as an antiviral tool due to its reactive species generation.
- The precise antiviral mechanisms of gas plasma remain largely unknown.
Purpose of the Study:
- To evaluate the antiviral activity of a clinically approved argon gas plasma device against murine coronavirus (MHV-GFP).
- To elucidate the mechanisms underlying gas plasma's antiviral action.
- To identify specific reactive species responsible for viral inactivation.
Main Methods:
- Utilized a high-content imaging assay to quantify MHV-GFP infection in murine fibroblasts (17Cl-1).
- Screened various antioxidants to identify reactive oxygen species (ROS) involved in antiviral effects.
- Assessed viral RNA integrity and virus particle morphology via electron microscopy.
Main Results:
- Argon gas plasma treatment delayed infectivity and reduced MHV-GFP infection and host cell toxicity.
- Glutathione, tyrosine, and cysteine offered significant protection against plasma-induced viral inactivation.
- Superoxide radicals and peroxynitrite were implicated as key mediators of viral inactivation.
- Extended plasma exposure led to MHV RNA degradation, suggesting RNA modification as a mechanism.
Conclusions:
- A clinically approved argon plasma jet demonstrates potent in vitro antiviral activity against a model coronavirus.
- Reactive species, particularly superoxide radicals and peroxynitrite, play a critical role in gas plasma's virucidal effects.
- Gas plasma represents a promising therapeutic tool for viral infections, with potential applications in clinical settings.
Related Concept Videos
Coronavirus
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly

